MedPath

Collection of Human Tissue Samples From the Neck Region for Characterization of Its Molecular and Biochemical Signatures

Active, not recruiting
Conditions
Obesity
Interventions
Procedure: Adults presenting for surgery in the neck area
Registration Number
NCT02274805
Lead Sponsor
AdventHealth Translational Research Institute
Brief Summary

The purpose of the study is to gather tissue (from the neck region), specimens (blood and urine) and medical record data from many patients and store them in one place so that scientists have the information they need to conduct research and learn about new ways to predict, identify and treat illness, specifically those related to obesity and diabetes.

Detailed Description

This protocol is designed to actively collect biospecimens (specifically, tissue from the neck region) and clinical data for donation to the TRI-MD, specifically, Dr. Sparks' laboratory. These specimens and data will be available to Dr. Sparks for future research activity in accordance with the Florida Hospital and Translational Research Institute for Metabolism and Diabetes (TRI) policies.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
34
Inclusion Criteria
  • Adults aged 18 and older presenting for surgery in the neck area
  • Able to provide informed consent
Exclusion Criteria
  • Unable to provide informed consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Adults presenting for surgery in the neck areaAdults presenting for surgery in the neck area-
Primary Outcome Measures
NameTimeMethod
Collection of brown adipose neck tissueDay of scheduled surgery

Any tissue deemed suitable by the surgeon and/or the research team during the neck surgery for the study's research objectives will be removed and collected for donation to this protocol. When there is enough tissue available, half will be snap frozen for extraction of DNA, RNA and protein. The other half will be cryopreserved for the future production of viable cells. When there is not enough tissue, the person collecting the samples will determine the processing. For research purposes, we aim to collect up to 500mg of each tissue.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Translational Research Institute for Metabolism and Diabetes

🇺🇸

Orlando, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath